Suppr超能文献

肺腺鳞癌临床病理特征的综合分析

Comprehensive analysis of clinicopathological profiles in adenosquamous carcinoma of the lung.

作者信息

Wang Yuanyuan, Guo Haoyue, Hou Likun, Wu Yuhan, Li Xuefei, Zhao Chao, Cheng Lei, Xiong Anwen

机构信息

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine Shanghai, China.

Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine Shanghai, China.

出版信息

Am J Transl Res. 2024 Jan 15;16(1):126-135. doi: 10.62347/UXQC3380. eCollection 2024.

Abstract

OBJECTIVES

Adenosquamous carcinoma (ASC), an uncommon subtype within non-small cell lung cancer (NSCLC), manifests distinctive traits of aggressiveness, embodying a fusion of both adenocarcinoma (AC) and squamous cell carcinoma (SCC) components. The clinicopathological characteristics of distinct subtypes of ASC remain unclear.

METHODS

This retrospective study included 226 patients diagnosed with lung ASC who consecutively underwent surgical resection at Shanghai Pulmonary Hospital, Tongji University, between January 2015 and March 2021. Data regarding the clinical features and pathological features were collected.

RESULTS

Out of this study cohort, 125 patients exhibited AC-predominant ASC, while 81 had SCC-predominant ASC. No significant differences were observed between the two subgroups in terms of age, gender, smoking history, primary site, and T, N classification. AC-Predominant ASC displayed a higher susceptibility to genetic alterations compared to SCC-Predominant ASC (P=0.02). Additionally, we showed that irrespective of the predominant pathological subtype in ASC, when lymph node metastasis occurred, the lymph node biopsies were more likely to exhibit AC, and a chi-square test confirmed that the primary predominant pathological subtype was not associated with the lymph node metastasis subtype.

CONCLUSIONS

In conclusion, we describe an overview of ASC in the Chinese population, and upon stratifying into predominant pathological subgroups, we observed a higher frequency of driver gene mutations in AC-predominant ASC. We found that the AC component in ASC has a higher propensity for lymph node metastasis. These findings may suggest the predominant role of the AC component within the context of ASC.

摘要

目的

腺鳞癌(ASC)是非小细胞肺癌(NSCLC)中一种不常见的亚型,具有独特的侵袭性特征,融合了腺癌(AC)和鳞状细胞癌(SCC)两种成分。不同亚型ASC的临床病理特征仍不明确。

方法

本回顾性研究纳入了226例诊断为肺ASC的患者,这些患者于2015年1月至2021年3月期间在同济大学附属上海市肺科医院连续接受手术切除。收集了有关临床特征和病理特征的数据。

结果

在本研究队列中,125例患者表现为AC为主型ASC,而81例为SCC为主型ASC。两个亚组在年龄、性别、吸烟史、原发部位以及T、N分期方面未观察到显著差异。与SCC为主型ASC相比,AC为主型ASC对基因改变的易感性更高(P = 0.02)。此外,我们发现,无论ASC中主要的病理亚型如何,当发生淋巴结转移时,淋巴结活检更有可能显示为AC,卡方检验证实原发主要病理亚型与淋巴结转移亚型无关。

结论

总之,我们描述了中国人群中ASC的概况,在分为主要病理亚组后,我们观察到AC为主型ASC中驱动基因突变的频率更高。我们发现ASC中的AC成分发生淋巴结转移的倾向更高。这些发现可能提示AC成分在ASC背景下的主要作用。

相似文献

1
Comprehensive analysis of clinicopathological profiles in adenosquamous carcinoma of the lung.
Am J Transl Res. 2024 Jan 15;16(1):126-135. doi: 10.62347/UXQC3380. eCollection 2024.
6
Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
World J Gastroenterol. 2017 Apr 14;23(14):2601-2612. doi: 10.3748/wjg.v23.i14.2601.

本文引用的文献

1
Clinicopathologic study of stage I adenosquamous carcinoma of the lung.
Jpn J Clin Oncol. 2023 Dec 7;53(12):1201-1207. doi: 10.1093/jjco/hyad122.
2
Clonal dynamics and Stereo-seq resolve origin and phenotypic plasticity of adenosquamous carcinoma.
NPJ Precis Oncol. 2023 Aug 26;7(1):80. doi: 10.1038/s41698-023-00430-8.
4
Clinical outcomes of immune checkpoint inhibitor therapy for advanced lung adenosquamous carcinoma.
J Thorac Dis. 2023 Feb 28;15(2):260-269. doi: 10.21037/jtd-22-1011. Epub 2023 Jan 9.
5
Narrative review of ferroptosis in obesity.
J Cell Mol Med. 2023 Apr;27(7):920-926. doi: 10.1111/jcmm.17701. Epub 2023 Mar 5.
6
Comprehensive analyses of genomic features and mutational signatures in adenosquamous carcinoma of the lung.
Front Oncol. 2022 Sep 14;12:945843. doi: 10.3389/fonc.2022.945843. eCollection 2022.
7
Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma.
Front Immunol. 2022 Aug 12;13:944812. doi: 10.3389/fimmu.2022.944812. eCollection 2022.
9
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.
J Thorac Oncol. 2022 Mar;17(3):362-387. doi: 10.1016/j.jtho.2021.11.003. Epub 2021 Nov 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验